Antiseptic Manufacturing in the US - Industry Market Research Report

Deep Cut: Industry Profit Will Likely Be Constrained by Disruptions to Global Transportation Channels

Consumer antiseptic sales have also risen as less unemployment and greater disposable income have prompted health-conscious consumers to spend more on personal antiseptics. An improving economy has also bolstered the accommodation and food service industries, which are major users of antiseptics and other products manufactured by this industry. As a result, industry revenue is expected to increase at an annualized rate of 4.8% to $1.1 billion over the five years to 2018, including projected growth of 3.4% in 2018. Industry profit, however, has been tempered by the passage of new US Food and Drug Administration (FDA) regulations requiring industry manufacturers to assure the safety and efficacy of their products. Stricter regulations will increase costs for existing industry operators. This industry manufactures antiseptic ampoules, tablets, capsules, vials, ointments, powders, solutions and suspensions. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.